G J Dietze

Author PubWeight™ 20.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998 2.06
2 Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 1999 1.51
3 Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens 1996 1.18
4 The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 1996 1.12
5 31P/1H WALTZ-4 broadband decoupling at 1.5 T: different versions of the composite pulse and consequences when using a surface coil. Magn Reson Imaging 1998 1.03
6 Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 1995 0.99
7 Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: possible involvement of kinins and prostaglandins. Mol Cell Endocrinol 1982 0.92
8 Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 1996 0.91
9 ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide. Am J Physiol 1999 0.90
10 Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes 1996 0.90
11 Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril. N Engl J Med 1988 0.90
12 Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance. Am J Physiol 1998 0.84
13 Metabolic effects of kinins: historical and recent developments. J Cardiovasc Pharmacol 1990 0.84
14 Improvement of glucose metabolism in patients with type II diabetes after treatment with a hemodialysate. Arzneimittelforschung 1996 0.83
15 Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. Circulation 2000 0.83
16 The effects of bradykinin and the ischemic isolated rat heart. Horm Metab Res Suppl 1990 0.81
17 Unveiling extracellular inorganic phosphate signals from blood in human cardiac 31P NMR spectra. J Cardiovasc Magn Reson 2001 0.79
18 Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin. Diabetes 1996 0.79
19 Artifacts in CSI-measurements caused by the drift of the static magnetic field. MAGMA 2000 0.78
20 31P nuclear magnetic resonance spectroscopy: a noninvasive tool to monitor metabolic abnormalities in left ventricular hypertrophy in human. Am J Cardiol 1999 0.78
21 Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy. Am J Cardiol 1997 0.78
22 Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 1996 0.77
23 Insulin enhances the bradykinin response in L8 rat skeletal myoblasts. Diabetes 2000 0.76
24 Augmented sympathetic response to bradykinin in the diabetic heart before autonomic denervation. Hypertension 2000 0.75
25 [Postreceptor defect in the effectiveness of insulin: significance of the kallikrein-kinin-prostaglandin system]. Beitr Infusionther Klin Ernahr 1986 0.75
26 Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy. J Magn Reson 1998 0.75
27 Bradykinin and skeletal muscle sugar uptake. J Appl Physiol (1985) 1987 0.75
28 Increased insulin-responsiveness by ACE-inhibition in noninsulin dependent diabetes mellitus. Adv Exp Med Biol 1989 0.75
29 Potential pitfall in the determination of free [Mg2+] by 31P NMR when using the beta/alpha-ATP peak height ratio method. MAGMA 1999 0.75
30 [Hormonal regulation of glucose secretion of the human liver in normal and disturbed metabolism]. Verh Dtsch Ges Inn Med 1981 0.75
31 Detection of monoester signals in human myocardium by 31P-MRS. MAGMA 1998 0.75
32 The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats. Life Sci 1999 0.75
33 Low-dose bradykinin infusion reduces endogenous glucose production in surgical patients. Metabolism 1988 0.75
34 Perspective: from increased energy metabolism to cardiac hypertrophy and failure: mediators and molecular mechanisms. Am J Cardiol 1999 0.75
35 [Substratum levels of human tissue in normal and disturbed metabolism]. Verh Dtsch Ges Inn Med 1981 0.75
36 Bradykinin infusion in long term postoperative parenteral nutrition improves nitrogen balance and protein synthesis. Adv Exp Med Biol 1989 0.75